A detailed history of Nfj Investment Group, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Nfj Investment Group, LLC holds 336,742 shares of FOLD stock, worth $3.19 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
336,742
Holding current value
$3.19 Million
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$5.84 - $8.57 $1.97 Million - $2.89 Million
336,742 New
336,742 $2.65 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Nfj Investment Group, LLC Portfolio

Follow Nfj Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nfj Investment Group, LLC with notifications on news.